These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6236183

  • 1. Radiosensitizers: a conference preview.
    Adams GE.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1181-4. PubMed ID: 6236183
    [No Abstract] [Full Text] [Related]

  • 2. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
    Yu NY, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
    [Abstract] [Full Text] [Related]

  • 3. Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
    Adams GE, Stratford IJ, Bremner JC, Edwards HS, Fielden EM.
    Radiother Oncol; 1991 Aug; 20 Suppl 1():85-91. PubMed ID: 2020774
    [No Abstract] [Full Text] [Related]

  • 4. Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward?
    Urtasun RC, Coleman CN, Wasserman TH, Phillips TL.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1691-6. PubMed ID: 6237083
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
    Hinchliffe M, McNally NJ.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of chemotherapy by hypoxic cell radiation sensitizers--a review.
    Siemann DW.
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1029-34. PubMed ID: 7050050
    [No Abstract] [Full Text] [Related]

  • 7. Sensitizers and protectors in radiotherapy.
    Brown JM.
    Cancer; 1985 May 01; 55(9 Suppl):2222-8. PubMed ID: 2983876
    [Abstract] [Full Text] [Related]

  • 8. Hypoxic cell radiosensitizers--present and future.
    Wasserman TH.
    Int J Radiat Oncol Biol Phys; 1981 Jun 01; 7(6):849-52. PubMed ID: 6457019
    [No Abstract] [Full Text] [Related]

  • 9. The effect of glutathione (GSH) depletion in vivo by buthionine sulfoximine (BSO) on the radiosensitization of SR 2508.
    Kramer RA, Soble M, Howes AE, Montoya VP.
    Int J Radiat Oncol Biol Phys; 1989 May 01; 16(5):1325-9. PubMed ID: 2523885
    [Abstract] [Full Text] [Related]

  • 10. Radiosensitizing effect of misonidazole in combination with an inhibitor of glutathione synthesis in murine tumors.
    Ono K, Komuro C, Nishidai T, Shibamoto Y, Tsutsui K, Takahashi M, Abe M.
    Int J Radiat Oncol Biol Phys; 1986 Sep 01; 12(9):1661-6. PubMed ID: 3759592
    [Abstract] [Full Text] [Related]

  • 11. Sensitizers and protectors in clinical oncology.
    Phillips TL.
    Semin Oncol; 1981 Mar 01; 8(1):65-82. PubMed ID: 6264627
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of misonidazole radiosensitization by buthionine sulphoximine.
    Rojas A, Smith KA, Soranson JA, Minchinton AI, Middleton RW, Denekamp J.
    Radiother Oncol; 1984 Dec 01; 2(4):325-32. PubMed ID: 6522642
    [Abstract] [Full Text] [Related]

  • 13. Clinical perspectives for the use of new hypoxic cell sensitizers.
    Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Sep 01; 8(9):1491-7. PubMed ID: 6216229
    [No Abstract] [Full Text] [Related]

  • 14. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW.
    Br J Cancer; 1982 Feb 01; 45(2):272-81. PubMed ID: 6460517
    [Abstract] [Full Text] [Related]

  • 15. Testing of new hypoxic cell sensitizers in vivo.
    Stone HB, Sinesi MS.
    Radiat Res; 1982 Jul 01; 91(1):186-98. PubMed ID: 6212963
    [No Abstract] [Full Text] [Related]

  • 16. Hypoxic cell radiosensitizers: expectations and progress in drug development.
    Coleman CN.
    Int J Radiat Oncol Biol Phys; 1985 Feb 01; 11(2):323-9. PubMed ID: 3156109
    [Abstract] [Full Text] [Related]

  • 17. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
    Lespinasse F, Biscay P, Malaise EP, Guichard M.
    Radiat Res; 1987 Apr 01; 110(1):149-54. PubMed ID: 2951766
    [Abstract] [Full Text] [Related]

  • 18. Enhancement in the aerobic toxicity of misonidazole and SR-2508 by buthionine sulfoximine and 4-hydroxypyrazole: the role of hydrogen peroxide.
    Tuttle SW, Biaglow JE, Varnes ME, Donahue LL, Clark EP, Epp ER.
    Int J Radiat Oncol Biol Phys; 1986 Jul 01; 12(7):1161-4. PubMed ID: 2943713
    [Abstract] [Full Text] [Related]

  • 19. 2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells.
    Wong KH, Wallen CA, Wheeler KT.
    J Neurooncol; 1991 Aug 01; 11(1):17-25. PubMed ID: 1833513
    [Abstract] [Full Text] [Related]

  • 20. Clinical experience with nitroimidazoles as radiosensitizers.
    Dische S, Saunders MI, Anderson P, Stratford MR, Minchinton A.
    Int J Radiat Oncol Biol Phys; 1982 Aug 01; 8(3-4):335-8. PubMed ID: 7107350
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.